Low, Philip Stewart

Back to all technologies

Innovations

Innovation Title Categories Lead Inventor
Targeting T Cells in Tumor Microenvironments through Immunotherapy
2019-LOW-68726
  1. Pharmaceuticals
  2. Medical/Health
Low, Philip Stewart
Bone Fracture Repair by Targeting of Bone Anabolic Agents
2015-LOW-67195
  1. Biomedical Engineering
  2. Pharmaceuticals
Low, Philip Stewart
CAFs are a leading reason for ineffective cancer treatments
2019-LOW-68704
  1. Chemistry and Chemical Analysis
  2. Biotechnology
Low, Philip Stewart
Selective Reprogramming of Pulmonary Macrophages for Treatment of Idiopathic Pulmonary Fibrosis
2019-LOW-68624
  1. Pharmaceuticals
Low, Philip Stewart
Fibroblast-targeted Drugs and Imaging for Improved Internalization and Retention
2019-LOW-68689
  1. Chemistry and Chemical Analysis
Low, Philip Stewart
Human Monoclonal Folate Receptor Beta Antibody
65627
  1. Biotechnology
  2. Medical/Health
Low, Philip Stewart
Therapy for Vaso-Occlusive Crisis in Sickle Cell Disease
2015-LOW-67127
  1. Pharmaceuticals
Low, Philip Stewart
Sensitive Folate Receptor Detection by Immunomagnetic Diffractometry
64872
  1. Biomedical Engineering
  2. Biotechnology
Savran, Cagri Abdullah
Selective Capture and Identification of Bacteria
65600
  1. Biomedical Engineering
  2. Biotechnology
Low, Philip Stewart

Details

Dr. Philip Low is the Ralph C. Corley Distinguished Professor of Chemistry and the Presidential Scholar for Drug Discovery at Purdue University. Dr. Low earned a B.S. from Brigham Young University and a Ph.D. from the University of California, San Diego. In 2015, Dr. Low received recognition with numerous awards including election to the National Academy of Inventors, the Mathias P. Mertes Award, the Roland T. Lakey Award, and the American Association for Cancer Research (AACR) Award for Outstanding Achievement in Chemistry in Cancer Research. Dr. Low received the 2014 Morrill Award, which recognizes faculty whose careers have demonstrated excellence in teaching, research, and in engagement missions. He was awarded the BioCrossroads 2013 Watanabe Life Sciences Champion of the Year Award. Dr. Low has received the National Institutes of Health MERIT Award and Purdue's awards for outstanding research and several national and international research awards. His research focuses on targeted therapeutics, fluorescence-guided surgery, techniques for pathogen detection, and the human red blood cell membrane's role in health and disease.

For additional information, visit Dr. Low's Purdue website https://www.chem.purdue.edu/activity/public/profile/chem/plow
or his Low Research Lab website: http://www.chem.purdue.edu/low/